Discounted Cash Flow Rating

Sell

Return on Equity Rating

Sell

Debt to Equity Rating

Buy

Price to Earnings Rating

Strong Buy

Analyst Rating

Buy

Simple Moving Average

Strong Sell

Exponential Moving Average

Strong Sell

Relative Strength Index

Buy

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Strong Buy

Wall Street Data Solutions Rating

Neutral

B

BeiGene, Ltd. American Depositary Shares (BGNE)

Pharmaceutical Preparations

https://www.beigene.com

BeiGene Ltd is a commercial-stage biotechnology company. It is engaged in the discovery and development of molecularly targeted and immuno-oncology drugs for the treatment of cancer. The company has developed a proprietary cancer biology platform that addresses the importance of tumor-immune system interactions and the value of primary biopsies in developing new models to support its drug discovery effort. It has developed clinical-stage drug candidates that inhibit the important oncology targets Bruton's tyrosine kinase, or BTK; RAF dimer protein complex and PARP family of proteins, and an immuno-oncology agent that inhibits the immune checkpoint protein receptor PD-1. Its geographical segments are China, the United States, and the Rest of the world.

C/O MOURANT GOVERNANCE SERVICES (CAYMAN), 94 SOLARIS AVENUE, CAMANA BAY
GRAND CAYMAN, E9

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

02/03/2016

Market Cap

20,937,653,675

Shares Outstanding

1,249,770,000

Weighted SO

104,209,169

Total Employees

N/A

Upcoming Earnings

08/07/2024

Similar Tickers

ASND --.--%

APLS --.--%

AKRO --.--%

BPMC --.--%

IMAB --.--%

KRYS --.--%

IMVT --.--%

MRTX --.--%

INCY --.--%

Beta

0.5900

Last Div

0.0000

Range

126.968-219.64

Chg

4.7800

Avg Vol

237833

Mkt Cap

20937653675

Exch

NASDAQ

Country

US

Phone

781-801-1800

DCF Diff

167.7930

DCF

-0.1530

Div Yield

0.0000

P/S

6.7616

EV Multiple

-23.1777

P/FV

6.0858

Div Yield %

0.0000

P/E

-39.1189

PEG

-0.9417

Payout

0.0000

Current Ratio

1.9801

Quick Ratio

1.7515

Cash Ratio

1.3492

DSO

69.3363

DIO

316.2046

Op Cycle

385.5409

DPO

237.5651

CCC

147.9758

Gross Margin

0.8348

Op Margin

-0.2862

Pretax Margin

-0.1520

Net Margin

-0.1691

Eff Tax Rate

-0.1124

ROA

-0.0917

ROE

-0.1493

ROCE

-0.2349

NI/EBT

1.1124

EBT/EBIT

0.5312

EBIT/Rev

-0.2862

Debt Ratio

0.1846

D/E

0.3133

LT Debt/Cap

0.0522

Total Debt/Cap

0.2385

Int Coverage

-32.6628

CF/Debt

-0.6675

Equity Multi

1.6969

Rec Turnover

5.2642

Pay Turnover

1.5364

Inv Turnover

1.1543

FA Turnover

1.9113

Asset Turnover

0.5421

OCF/Share

-6.7236

FCF/Share

-12.6492

Cash/Share

24.9842

OCF/Sales

-0.2273

FCF/OCF

1.8813

CF Coverage

-0.6675

ST Coverage

-0.8098

CapEx Coverage

-1.1347

Div&CapEx Cov

-1.1347

P/BV

6.0858

P/B

6.0858

P/S

6.7616

P/E

-39.1189

P/FCF

-15.8097

P/OCF

-29.1021

P/CF

-29.1021

PEG

-0.9417

P/S

6.7616

EV Multiple

-23.1777

P/FV

6.0858

DPS

0.0000

Latest Headlines (EST)

The Motley Fool Jan 15, 06:30 5 Biotech Stocks That Could Be Big Winners in 2024 and Beyond Benzinga Jan 10, 09:22 As China's Population Declines In 2023, Will Aging Demographics Boost Healthcare Stocks?

Revenue Product Segmentation